Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
5(38%)
Results Posted
0%(0 trials)
Terminated
3(23%)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
4
31%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

5

trials recruiting

Total Trials

13

all time

Status Distribution
Active(5)
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Recruiting5
Completed4
Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
5
Success Rate
57.1%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

unknown18%
completed431%
recruiting538%
terminated323%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
13